Prevalence of factor V leiden in African-Americans

Research Communications in Molecular Pathology and Pharmacology

Volumn 99, Issue 3, 1998, Pages 339-343

  Mack, Richard ^a   Samaan, Pauline ^a   Podolak, Irena ^a   Albanese, Ernest ^a  

^a University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ARTICLE; DNA DETERMINATION; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; NEGRO; POINT MUTATION; PRIORITY JOURNAL;

EID: 0031917988     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Arruda, V.R., Annichino-Bizzacchi, J.M., Costa, F.F. and Reitsma P.H. (1995). Factor V Leiden (FVQ 506) is common in a Brazilian population. Am. J. Hematol. 49:242-243
2. Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. and Reitsma, P.H. (1994). Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
3. Dahlback, B., Carlsson, M. and Svensson, P.J. (1993). Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc. Natl. Acad. Sci. USA 90:1004-1008
4. de Maat, M.P.M., Kluft, C., Jespersen, J. and Gram, J. (1996). World distribution of factor V Leiden mutation. Lancet 347:58
5. Gou, D., Naipal, A. and Reitsma, P.H. (1996). World distribution of factor V Leiden mutation. Lancet 347:59
6. Hallam, P.J., Millar, D.S., Krawczak, M., Kakkar, V.V. and Cooper, D.N. (1995). Population difference in the frquency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency. J. Med. Genet. 32:543-545
7. Kahn, M.J., Scher, C., Rozans, M., Michaels, R.K., Leissinger, C. and Krause, J. (1997). Factor V Leiden is not responsible for stroke in patients with sickling disorder and is uncommon in African Americans with sickle cell disease. Am. J. Hematol. 54:12-15
8. Kirschbaum, N.E. and Foster, P.A. (1995). The polymerase chain reaction with sequence specific primers for the detection of the Factor V mutation associated with activated protein C resistance. Thromb Hemostasis 74:874-878
9. Koster, T., Rosendaal, F.R., deRonde, H., Briet, E., Vandenbroucke, J.P. and Bertina, R.M. (1993). Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-1506
10. Rees, D.C., Cox, M. and Clegg, J.B. (1995). World distribution of Factor V Leiden. Lancet 346:1133-1134
11. Simioni, .P, de Ronde, H., Prandoni, P., Saladini, M., Bertina, R.M. and Girolami, A. (1995). Ischemic stroke in young patients with activated protein C resistance. Stroke 26:885-890
12. Wright, J.G., Cooper, P., Malia, R.G., Kulozik, A.E., Vetter, B., Thomas, P., Preston, F.E. and Serjeant, G.R. (1997). Activated protein C resistance in homozygous sickle cell disease. Brit. J. Haematol. 96:854-856